AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Tempus and Recursion Extend Data License Agreement and License New RNA Foundation Model
Sep 21, 2026•about 3 hours ago
Contract Type
agreement
ChicagoOtherBiotechnology
Description
Tempus AI, Inc. has announced an extension of its data license agreement with Recursion Pharmaceuticals, extending their partnership through November 2029. The companies aim to advance precision medicine using foundation models, with amended license fees totaling $42 million over the next three years.
Company Information
Company
Tempus AI
Location
Chicago, Illinois, United States
About
Tempus AI, Inc. is a leader in artificial intelligence and precision medicine.